BA
The Boeing Company
BA's outlook is improving, though it still trails on the overall score.
ZWS
Zurn Elkay Water Solutions Corporation
ZWS has the edge over BA overall, supported by stronger valuation and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ZWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
ZWS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over ZWS in the historical PE scenario, which offers more potential upside but is not a forecast.
ZWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $45.17 | — |
| Cheap | 25x | $42.43 | -6.1% |
| Current | 26x | $45.17 | — |
| Fair | 40x | $67.68 | +50% |
| Expensive | 48x | $81.44 | +80% |
Historical ranges are pointers, not guarantees.
ZWS's PE is in its cheap range at 26x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
ZWS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ZWS, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
ZWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.99 | +17% |
| Q3 2026 | $1.71 | +53% |
| Q2 2026 | $1.62 | +60% |
| Q1 2026 | $1.24 | +25% |
| Q4 2025 | $1.15 | +25% |
| Q3 2025 | $1.12 | +44% |
| Q2 2025 | $1.01 | +31% |
| Q1 2025 | $0.99 | +41% |
| Q4 2024 | $0.92 | +44% |
ZWS has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
ZWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $495.1M | +8.7% |
| Q2 2026 | $491M | +10% |
| Q1 2026 | $433M | +11% |
| Q4 2025 | $407.2M | +9.8% |
| Q3 2025 | $455.4M | +11% |
| Q2 2025 | $444.5M | +7.9% |
| Q1 2025 | $388.8M | +4% |
| Q4 2024 | $370.7M | +3.9% |
ZWS's revenue has grown year over year for 12 quarters in a row: $495M last quarter, up 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +4.8 points |
| Q2 2026 | 31% | +14 points |
| Q1 2026 | 19% | +2.7 points |
| Q4 2025 | 15% | +1.5 points |
| Q3 2025 | 17% | -0.1 points |
| Q2 2025 | 17% | 0 points |
| Q1 2025 | 16% | +2.1 points |
| Q4 2024 | 13% | +4.1 points |
ZWS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
ZWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $112.2M | +11% |
| Q2 2026 | $162.3M | +47% |
| Q1 2026 | $46.1M | +7.5% |
| Q4 2025 | $91.7M | +44% |
| Q3 2025 | $101.3M | +11% |
| Q2 2025 | $110.6M | +30% |
| Q1 2025 | $42.9M | -20% |
| Q4 2024 | $63.6M | +9.3% |
ZWS generated $412M in free cash flow over the past year, up 29% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
ZWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 0.9x | Very low |
ZWS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ZWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 15.1 | Oversold |
ZWS's weekly RSI is 44 (neutral) and its Stochastic is 15 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over ZWS on valuation relative to its sector.
ZWS PE vs Industrials Sector
| Metric | ZWS | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 9.8% above |
| PE % | 18 | 58 | 40 pts below |
ZWS is trading at 26x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ZWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.2 | 2.3% below |
| 20 week MA | $47.6 | 5.1% below |
| 50 week MA | $47.9 | 5.8% below |
| 100 week MA | $43.7 | 3.4% above |
| 200 week MA | $36.5 | 24% above |
ZWS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
ZWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.8 | $18.9 | +20% |
| 2021 | $18.9 | $36.1 | +91% |
| 2022 | $36.1 | $21.4 | -41% |
| 2023 | $21.4 | $29.4 | +37% |
| 2024 | $29.4 | $37.7 | +28% |
| 2025 | $37.7 | $47.8 | +27% |
| 2026 YTD | $47.8 | $45.2 | -5.6% |
ZWS has the edge over BA on returns for 2026, with the stronger performance.